Clinical trials recruiting for Type 1 diabetes

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
  NCT07284511 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
  NCT07260110 · Phase: Not specified · Ages: 8 Years and older · Sex: All (male and female) · 1 location
• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
  NCT07061574 · Phase: Phase 1, Phase 2 · Ages: 9 Years to 20 Years · Sex: All (male and female) · 10 locations
• A Trial of Three- and Seven-days Insulin Infusions Set
  NCT06532461 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 18 Years · Sex: All (male and female) · 1 location
• ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
  NCT05463289 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 21 Years · Sex: All (male and female) · 1 location
• Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
  NCT05153070 · Phase: Phase 2 · Ages: 16 Years to 45 Years · Sex: All (male and female) · 1 location
• DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
  NCT07638345 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Danish Diabetes Birth Registry 2
  NCT05678543 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Denosumab for Type 1 Diabetes
  NCT06524960 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 3 locations
• Early Detection of Type 1 Diabetes
  NCT06984185 · Phase: Not specified · Ages: 1 Year to 18 Years · Sex: All (male and female) · 1 location
• Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
  NCT07097818 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years and older · Sex: All (male and female) · 10 locations
• EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
  NCT07212530 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 16 Years · Sex: All (male and female) · 1 location
• GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
  NCT06338553 · Phase: Early Phase 1 · Ages: 12 Years to 50 Years · Sex: All (male and female) · 1 location
• Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
  NCT07573228 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 50 Years · Sex: All (male and female) · 1 location
• Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
  NCT06272136 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes
  NCT06563401 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · 1 location
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
  NCT06082063 · Phase: Phase 3 · Ages: 40 Years to 90 Years · Sex: All (male and female) · 2 locations
• NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
  NCT07560813 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Prevalence of NAFLD in T1DM Patients
  NCT06445361 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
  NCT05713448 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
  NCT06966427 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 75 Years · Sex: All (male and female) · 2 locations
• Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
  NCT07457580 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 14 locations
• Registry for Stage 2 Type 1 Diabetes
  NCT06481904 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 37 locations
• Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control
  NCT06875167 · Phase: Not specified · Ages: 2 Years to 6 Years · Sex: All (male and female) · 1 location
• Simultaneous Measurement and Responsive Treatment - Part 2
  NCT07655076 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
  NCT06435156 · Phase: Phase 2 · Ages: 18 Years to 84 Years · Sex: All (male and female) · 34 locations
• Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
  NCT07413874 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
  NCT05734313 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · 2 locations
• The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
  NCT06976619 · Phase: Phase 2 · Ages: 25 Years to 70 Years · Sex: All (male and female) · 1 location
• The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
  NCT05414409 · Phase: Phase 2 · Ages: 11 Years to 18 Years · Sex: All (male and female) · 1 location
• Type 1 Diabetes Adolescents for Healthier Lifestyles Study
  NCT06878872 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 18 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Type 1 diabetes often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Type 1 diabetes trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.